Contracts › HT942523C0095
HT942523C0095: Research and Development Contract - Proposal JW220021 - Contract Proposal Title - Evaluating the Safety and Ease of Use of Counterflow Hemostatic Gauze for Extreme Cold Environments
Awarded to Versiti Blood Health, Inc. by Defense Health Agency.
$6.5Mobligated
$6.5Mpotential value
24 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942523C0095 |
|---|---|
| Awardee | Versiti Blood Health, Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | WI |
| Offers received | 1 |
| Period of performance | 25 September 2023 to 24 December 2026 |
| Potential end | 24 December 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record